Industry: Biotechnology (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2025-05-15 | New | $50,000 | $50,000 | Equity and Debt | 04 | SEC link |
Name | Role |
---|---|
Prakash Krishna Mandgi | Director, Executive |
Krishna Ravindranathan | Director, Executive |